Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certification & Accreditation
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Features
AMS Features
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
Changing within the same class: efficacy of brodalumab in plaque psoriasis after treatment with an IL-17A blocker – a retrospective multicenter study
By
- AMS
posted
Mar 06, 2020 10:27 AM
0
Recommend
Volume 32, Issue 8
, December 2021, Page 878-882
.
0 comments
0 views
Related Content
Should the presence of psoriatic arthritis change how we manage psoriasis?
- AMS
Added Nov 26, 2021
Blog Entry
Therapeutic outcomes of pemphigus in a referral service in Northern Brazil: a retrospective study of 32 patients
- AMS
Added Jan 24, 2020
Blog Entry
Correct performance of subcutaneous injections in plaque psoriasis: comparison of trained and untrained patients with different application systems in routine clinical care
- AMS
Added Feb 03, 2020
Blog Entry
Concomitant atopic dermatitis and psoriasis – a retrospective review
- AMS
Added Dec 18, 2019
Blog Entry
Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study
- AMS
Added Aug 13, 2021
Blog Entry
Permalink
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic